View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Theme
  2. Macro
  3. Covid-19
February 17, 2021

Coronavirus company news summary – UK Government funds Covid-19 Phase I studies – LifeArc provides funding to UK Covid-19 research

By Allie Nawrat

17 February 2021

The UK Government has announced funding to a Phase I clinical trial platform to fast-track research and development of the most innovative Covid-19 treatments. The move will allow the best researchers to study treatments in the UK  and will also offer cutting-edge treatments to NHS patients in months rather than years.

Medical research charity LifeArc announced that it will be providing in $6.94m funding to assist the GenOMICC Covid-19 study carried out by the GenOMICC consortium and Genomics England. Launched in May 2020, the study uses genomics to understand why some people are severely affected by Covid-19.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology